Research archive

Cynthia Collins

Cynthia Collins, Director (Independent) at Certara, Inc.. Biography, career history and compensation sourced from Certara, Inc. proxy statement (SEC Schedule 14A).

About

Cynthia Collins has served as a Certara director since 2021 and sits on the Audit Committee; she provided notice of her resignation effective upon the election of the Class III directors at the May 14, 2026 annual meeting. She has been CEO of several pharmaceutical and biotechnology companies, most recently Editas Medicine, and earlier Human Longevity, GenVec and Sequoia Pharmaceuticals, with senior roles at GE Healthcare, Beckman Coulter and Baxter Healthcare. She has served on the boards of Codexis, DermTech and MaxCyte.

Roles

Certara, Inc.

Director (Independent) · Current role

2021–present

Editas Medicine, Inc.

CEO & Director

—

Human Longevity, Inc.

CEO

—

GenVec

CEO

—

GE Healthcare

Senior management

—

External Roles

Codexis, Inc.

Director

—

DermTech

Director

—

MaxCyte, Inc.

Director

—

Also at Certara, Inc.

Chief Executive Officer & Director

James Cashman III

Chairman of the Board (Independent)

Director (Arsenal-designated)

Related

Certara Analytica Laser 2018

Certara Applied Biomath Abm 2023

See how Top Bucket AI works for your firm

Top Bucket AI Research

Stay ahead of private markets

Research and market intelligence for private-markets professionals.

✓

You're subscribed.

Thanks for signing up.

Dated reference snapshot as of September 10, 2026. This is not a live financial feed. Verify figures against primary filings before relying on them.